- Rating
- 2
- Confidence
- 2
- Informativeness
- 2
- Presentation
- 3
- Soundness
- 2
Read review
Paper summary
This paper proposes BRIDGE, a framework for predicting spatial gene expression from H&E histology images by leveraging non-target support genes during training. The central idea is to learn latent co-expression programs from support-gene expression and use these programs to guide morphology representation learning and target-gene prediction.
The framework consists of three modules: (1) a Local Morphology Encoding Module that extracts morphology features and target-gene representations using pretrained encoders; (2) a Co-expression Program Learning Module that applies non-negative matrix factorization (NMF) to support-gene expression and uses the resulting program representations as queries for morphology aggregation; and (3) a Gene-Adaptive Decoding Module that combines program-specific morphology features and target-gene embeddings through adaptively weighted experts. Experiments on three spatial transcriptomics datasets (ANDERSSON, LYMPH IDC, and LUAD) demonstrate the effectiveness of the proposed method.
Critical strengths
-
The paper introduces an interesting approach to exploiting non-target gene expression as additional supervision for spatial gene expression prediction. Specifically, BRIDGE derives cohort-adaptive latent co-expression programs using NMF and transforms them into program-specific queries for morphology aggregation. These representations are subsequently incorporated into a gene-adaptive prediction framework. Importantly, support-gene expression is used only during training and is not required during inference. This design provides a potentially useful way to leverage additional molecular information without increasing the inference-time data requirements.
-
The consistent improvements across multiple evaluation datasets demonstrate the effectiveness of the proposed method. For example, BRIDGE achieves the lowest MAE and MSE on all three evaluated datasets and the highest PCC on ANDERSSON and LUAD.
Critical weaknesses
-
My main concern is that the paper claims that non-target gene co-expression programs provide complementary molecular information that improves morphology-based prediction. However, most of the evidence demonstrates improved prediction performance, rather than directly validating the learned programs. For example, the original NMF programs may not remain biologically meaningful after optimization. The performance improvements attributable specifically to program structure are relatively modest.
-
My second concern is the generalization. The experimental evaluation relies on relatively small numbers of independent patients, particularly in LYMPH IDC (four patients) and LUAD (two patients). Although the use of patient-disjoint splits is appropriate, the limited cohort sizes make it difficult to establish the robustness of the reported improvements. Several PCC gains are relatively modest, and comprehensive patient-level paired statistical analyses are not provided. More importantly, the cross-cohort transfer experiment shows only a marginal improvement in PCC (0.226 versus 0.224), despite improvements in MAE and MSE, suggesting that the learned representations may not reliably capture spatial gene expression variation under domain shift.
-
My last concern is that the submission exceeds the 9-page limit, with four lines extending onto Page 10.
Questions for authors
Q1: How can the authors verify that the learned programs preserve meaningful co-expression information?
Q2: Are the reported improvements statistically reliable at the patient level?
Q3: How much improvement comes specifically from NMF co-expression structure rather than generic additional supervision?
Q4: How should the cross-cohort results be interpreted given the low PCC?